Zobrazeno 1 - 10
of 173
pro vyhledávání: '"ORLY VARDENY"'
Autor:
Ankeet S. Bhatt, Muthiah Vaduganathan, Brian L. Claggett, Ian J. Kulac, Inder S. Anand, Akshay S. Desai, James C. Fang, Adrian F. Hernandez, Pardeep S. Jhund, Mikhail N. Kosiborod, Marc S. Sabatine, Sanjiv J. Shah, Orly Vardeny, John J. V. McMurray, Scott D. Solomon, Thomas A. Gaziano
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background The sodium glucose cotransporter‐2 inhibitors are guideline‐recommended to treat heart failure across the spectrum of left ventricular ejection fraction; however, economic evaluations of adding sodium glucose cotransporter‐2 inhibito
Externí odkaz:
https://doaj.org/article/53dbb9210acf48109e85b415aa980e57
Autor:
Magnus O. Wijkman, Marcus V.B. Malachias, Brian L. Claggett, Susan Cheng, Kunihiro Matsushita, Amil M. Shah, Pardeep S. Jhund, Josef Coresh, Scott D. Solomon, Orly Vardeny
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 10, Pp 1887-1896 (2021)
Abstract More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long‐term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We a
Externí odkaz:
https://doaj.org/article/b7ec8b8f90a3457a905ce74c16c91519
Autor:
Nell J Marshall, Jennifer L Lee, Jessica Schroeder, Wei-Nchih Lee, Jermyn See, Mohammad Madjid, Mrudula R Munagala, John D Piette, Litjen Tan, Orly Vardeny, Michael Greenberg, Jan Liska, Monica Mercer, Sandrine Samson
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 10, p e38710 (2022)
BackgroundSeasonal influenza affects 5% to 15% of Americans annually, resulting in preventable deaths and substantial economic impact. Influenza infection is particularly dangerous for people with cardiovascular disease, who therefore represent a pri
Externí odkaz:
https://doaj.org/article/f654987120274b149b144a29d0ae5017
Autor:
Muhammad Shahzeb Khan, Izza Shahid, Stefan D. Anker, Scott D. Solomon, Orly Vardeny, Erin D. Michos, Gregg C. Fonarow, Javed Butler
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-13 (2020)
Abstract Background Due to the overlapping clinical features of coronavirus disease 2019 (COVID-19) and influenza, parallels are often drawn between the two diseases. Patients with pre-existing cardiovascular diseases (CVD) are at a higher risk for s
Externí odkaz:
https://doaj.org/article/08a49189604b4bfaa34312c2ff58fb05
Autor:
Daniel Modin, Brian Claggett, Mads Emil Jørgensen, Lars Køber, Thomas Benfield, Morten Schou, Jens‐Ulrik Stæhr Jensen, Scott D. Solomon, Ramona Trebbien, Michael Fralick, Orly Vardeny, Marc A. Pfeffer, Christian Torp‐Pedersen, Gunnar Gislason, Tor Biering‐Sørensen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Background Influenza infection may increase the risk of stroke and acute myocardial infarction (AMI). Whether influenza vaccination may reduce mortality in patients with hypertension is currently unknown. Methods and Results We performed a nationwide
Externí odkaz:
https://doaj.org/article/d3e36accebca47b685b2d8a2ac2d112c
Autor:
April F. Mohanty, Emily B. Levitan, Jordan B. King, John A. Dodson, Orly Vardeny, James Cook, Jennifer S. Herrick, Tao He, Olga V. Patterson, Patrick R. Alba, Patricia A. Russo, Engels N. Obi, Michelle E. Choi, James C. Fang, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 20 (2021)
Background Sacubitril/valsartan, a first‐in‐class angiotensin receptor neprilysin inhibitor, received US Food and Drug Administration approval in 2015 for heart failure with reduced ejection fraction (HFrEF). Our objective was to describe the sac
Externí odkaz:
https://doaj.org/article/b3e4d96313984c458e4300e40728aa41
Autor:
Sara B. Seidelmann, Orly Vardeny, Brian Claggett, Bing Yu, Amil M. Shah, Christie M. Ballantyne, Elizabeth Selvin, Calum A. MacRae, Eric Boerwinkle, Scott D. Solomon
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 4 (2017)
BackgroundElevated B‐type natriuretic peptide (BNP) levels are associated with heart failure and increased mortality in the general population. We investigated rs198389, a functional variant in the promoter region of the BNP gene (NPPB), in patient
Externí odkaz:
https://doaj.org/article/c42f4f2028ad44f9a79724154e19e8eb
Autor:
Jawad H. Butt, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, James C. Fang, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, Jose Walter Cabrera Honorio, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Lars Køber, Carolyn S.P. Lam, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Orly Vardeny, Eileen O'Meara, Jose F.K. Saraiva, Sanjiv J. Shah, Muthiah Vaduganathan, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
Publikováno v:
JACC: Heart Failure. 11:375-388
Background: Black people have a higher incidence and prevalence of heart failure (HF) than White people, and once HF has developed, they may have worse outcomes. There is also evidence that the response to several pharmacologic therapies may differ b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83593bbced871479864f3145e8a3ea4
https://doi.org/10.1016/j.jchf.2022.11.014
https://doi.org/10.1016/j.jchf.2022.11.014
Autor:
Xiaowen Wang, Muthiah Vaduganathan, Brian L. Claggett, Sheila M. Hegde, Maria Pabon, Ian J. Kulac, Orly Vardeny, Eileen O’Meara, Shelley Zieroth, Tzvetana Katova, Martina M. McGrath, Anne-Catherine Pouleur, Pardeep S. Jhund, Akshay S. Desai, Silvio E. Inzucchi, Mikhail N. Kosiborod, Rudolf A. de Boer, Lars Kober, Marc S. Sabatine, Felipe A. Martinez, Piotr Ponikowski, Sanjiv J. Shah, Adrian F. Hernandez, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon, Carolyn S.P. Lam
Publikováno v:
Circulation, 147(8), 624-634. Lippincott Williams & Wilkins
Background: Sodium-glucose cotransporter-2 inhibitors have emerged as a key pharmacotherapy in heart failure (HF) with both reduced and preserved ejection fraction. The benefit of other HF therapies may be modified by sex, but whether sex modifies th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19f13c28bd62f540572b6db0cc04047
https://pure.eur.nl/en/publications/f55d8c12-2c61-4ba7-95c9-2335b4e9a690
https://pure.eur.nl/en/publications/f55d8c12-2c61-4ba7-95c9-2335b4e9a690
Autor:
Ankeet S. Bhatt, Matthew Dimond, Mona Fiuzat, Muthiah Vaduganathan, Orly Vardeny, Punag Divanji, Jan Komtebedde, Martin P. Lefkowitz, Richard Nkulikiyinka, Magnus Petersson, Lothar Roessig, Daniel Schaber, Christopher M. O’Connor, Scott D. Solomon
Publikováno v:
JACC: Heart Failure. 11:254-257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aef1f4cab04520bbd8b8cdaad69e328c
https://doi.org/10.1016/j.jchf.2022.11.024
https://doi.org/10.1016/j.jchf.2022.11.024